| abstract |
The present invention relates to compounds of the Formula I, the pharmaceutically acceptable salts and stereoisomers thereof, which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions in mammals: n n n n n n n n n n n n wherein n is an integer, preferably n is 1; n wherein R 1 and R 2 are independently selected from the group consisting of: |